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1. Introduction 
Progressive transformation of disease profiles in the world can be partially explained by the 
existence of chronic diseases, as they are responsible for a large part of the worldwide 
morbidity and mortality rates, thus becoming pandemics. One of the diseases recognized as 
a public health problem is chronic renal failure (CRF) because of the negative impact it has 
on the health and health-related quality of life (HRQOL) of its sufferers (Atkins, 2005a, 
2005b). 
The concept of HRQOL is still inaccurate because it has been approached from a variety of 
disciplines such as philosophy, economics, medicine, sociology, public health, politics, 
ethics, etc. (Cardona & Agudelo, 2005).  
According to the World Health Organization (WHO), HRQOL is the "individual's 
perception of their position in life in the context of the culture and value systems in which 
they live and in relation to their goals, expectations, standards and concerns." (WHO, 2002) 
This concept includes physical and psychological aspects as well as the degree of 
independence, social relationships, environment and spirituality (Cardona et al., 2003). The 
approximately four hundred instruments for measuring HRQOL (Cardona & Agudelo, 
2005) can be grouped into four categories: the ones that measure HRQOL in terms of its 
global definition, the ones using component-oriented approaches, those which focus on one 
component, and the combinations of any of the above (Fleury & Lana Da Costa, 2004).  
The relationship between HRQOL in CRF patients and the treatment after renal failure has 
been studied repeatedly (Amoedo et al., 2004; De Alvaro et al., 1997; García et al., 2003; 
Leanza et al., 2000; Pérez et al., 2007; Rebollo et al., 1999, 2000a, 2000b;  Sanz et al., 2004). 
However, there are insufficient studies on the relationship between early progression of 
renal damage and well-being (National Kidney Foundation [NKF], 2007). The 
recommendations of the Institute of Medicine (IOM) Workshop “Assessing Health and 
health-related quality of life Outcomes in Dialysis” are recorded in the KDOQI guidelines 
and supported by scientific evidence. The IOM recommends assessing the aforementioned 
relationship with valid, reliable, and useful instruments such as the Medical Outcomes 
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Study 36-Item Short Form (SF-36). The version used in this study was adapted for the 
Colombian culture (Lugo et al., 2006).  
To follow the WHO's recommendation (Tazeen, 2006), the Colombian Ministry of Social 
Protection proposed a CRF prevention and control program for Colombian healthcare 
providers (Martínez & Valencia, 2005). One of such institutions has been developing a renal 
protection program (RPP) since 2004. Besides patient uptake and follow-up, this program 
also assists patients in the early stages of the condition to prevent progression and renal 
damage, to delay the need for renal replacement therapies (RRT). The Renal Protection 
Program (RPP) is an interdisciplinary healthcare program. It is based on a protocol that 
establishes educational talks and regular medical appointments for conducting clinical 
examinations and laboratory tests. The program is geared toward CKD patients and 
welcomes them since the early stages of their condition. Likewise, the program actively 
searches for early-stage CKD patients and refers them to nephrologists. The professionals 
involved in this program are: general practitioners, internists, nutritionists, nurses, and 
nephrologists. Their degree of involvement varies depending on the patients' CKD stage. 
First, a follow-up is performed on the underlying condition. Afterwards, patients in the first 
and second stages of CKD are assigned to the program's first healthcare level, which offers 
medical appointments with internists and nutrition professionals once per year for stage 1 
patients, and every semester for stage 2 patients. The second healthcare level of the program 
is for patients in stages 3 and 4, and offers medical appointments with internists, 
nephrologists, and nutritionists every three years for stage 3 patients and every two months 
for stage 4 patients. 
In contrast, other Colombian healthcare providers offered conventional treatment (CT) in 
2004. CT consists of providing healthcare through general medicine once the patients feel 
the need to request this service. Conventional treatment follows no healthcare guidelines, 
does not search for patients actively, and offers no laboratory tests or regular appointments.  
This study compares changes in the HRQOL of two patient groups during the early stages 
of CRF (one group having been exposed to a RPP from 2007 to 2008). Its aim is to provide 
evidence of interventions that ease the burden this disease represents for patients, families 
and society. 
2. Methods 
A longitudinal study on two representative samples consisting of CRF patients in 
predialysis. The first group followed a renal protection program, and the other conventional 
treatment (CT). SF-36 questionnaire was applied twice for both groups, with an interval of 
one year. The RPP actively searches for patients and interdisciplinary standardized 
professional care, whereas CT consists of patient-requested medical care and follows no 
protocol.  
The eligible population consisted of 5884 people complying with the following criteria: a. 
Having health insurance with either of the two healthcare promoting institutions during 
2007; b. Having a CRF diagnosis that complies with the criteria established in the 2007 
KDOQI guidelines (NKF,2007); c. Being older than 16, and d. Having received no dialysis or 
renal transplants. Exclusion criteria: being registered with both healthcare providers during 
the follow-up year. 
www.intechopen.com
Health-Related Quality of Life in Chronic Renal Predialysis  
Patients Exposed to a Prevention Program – Medellín, 2007-2008 
 
433 
A formula with repeated measurements proposed by Frison and Pocock in 1992 (Frison et 
al., 1992) was used to calculate the sample probabilistically. The criteria were: type 1 error: 
0.05, type 2 error: 0.20 (Power: 80%), a difference of 10 in the average value of both groups, a 
standard deviation (SD) of 34 for both groups (the highest SD observed during the 
validation of the SF-36 domains (Lugo et al., 2006). The correlation between basal and 
follow-up measurements was fixed at 0.5.  
The minimal sample size for each group was 137. There was a total of 274 patients. The 
researchers anticipated that locating patients would be difficult due to high mobility. 
Therefore, an oversampling of 50% was performed, obtaining a final sample of 411 patients, of 
which only 293 could be contacted. The sample for the healthcare provider offering the RPP 
consisted of 148 patients, and the sample for the healthcare provider offering conventional 
treatment consisted of 145 patients. This guaranteed the expected representativeness.  
The SF-36 consists of eight domains that were calculated by transforming the ordinal scale 
of the form's items into the corresponding score from 0 to 100 (Lugo et al., 2006). This model 
has been used to define two summary scores, namely: the physical health summary score 
(PCS1) and the mental health summary score (MCS1). Each of these two components 
includes four SF-36 dimensions as follows: PCS1 includes physical functioning (PF), role-
physical (RP), body pain (BP) and general health (GH); MCS1 includes: vitality (V), social 
functioning (SF), role-emotional (RE) and mental health (MH). Furthermore, summary 
scores for physical and mental health were calculated using the same method applied in a 
reproducibility study of the SF-36 summary scores in HRQOL assessments for 
Schizophrenia patients (Leese et al., 2008). 
Physical functioning (PF) is measured by assessing the ability to perform different kinds of 
simple and strenuous activities. Role physical (RP) is measured based on how much patients 
can devote themselves to their jobs and other activities. Bodily pain (BP) is measured based on 
pain intensity and on how it hinders daily work. General Health (GH) refers to the patients' 
assessment of their own health. Vitality (V) is measured by assessing the perception of energy, 
exhaustion, or fatigue. Social functioning (SF) is measured by observing how much the 
patients' health problems affect their social activities. Role emotional (RE) is measured in terms 
of what activities the patients stop doing due to emotional problems. Mental health (MH) is 
measured by assessing how nervous, sad, calm, discouraged, or happy the patients feel. 
Change in health has a scale which is independent from the aforementioned domains and is 
used to assess the health state of patients. The current health state is compared with the one 
exhibited by the same individual one year prior to the measurement.  
Upon receiving the patient's informed consent, the SF-36 was administered by qualified 
medicine students. Also, its correct administration was verified and double data entry was 
used to ensure reliability. 
One year later the total number of patients surveyed with the SF-36 was 133 for the RPP and 
130 for CT. For the second application of the SF-36, data analysis was carried out assigning 
zero to the domains of deceased patients and imputing the remaining missing values 
through multiple linear regression (Alisson, 2001).  
After imputing the domains, summary scores were calculated and their distribution explored 
using the Kolmogorov-Smirnov test to verify the normality assumption. A comparison was 
made between the HRQOL values obtained in the two measurements for each group. For this 
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purpose, the t-student test for independent samples or the Mann-Whitney U test were used. 
Likewise, the changes in HRQOL values within each group were compared using the t test for 
related samples or Wilcoxon's rank sum test. The report was generated by analyzing the 
means in order to establish comparisons between our results and the scientific literature. 
For each summary score and dimension of the HRQOL perceived after one follow-up year, 
the adjusted mean was calculated to compare both interventions using an analysis of 
covariance model (ANCOVA) and a two-way analysis of variance adjusted for gender and 
history of hypertension, diabetes and dyslipidemia. The ANCOVA's covariables were: the 
HRQOL scores obtained at the start of the study, age, and stage of the condition.  
Furthermore, the effect size of HRQOL differences was calculated using Cohen's effect size 
index and its corresponding Hedges' bias correction formula (Cohen, 1988). All analyses 
were conducted using the program SPSS version 15. 
3. Results 
3.1 Demographic and clinical characteristics 
The median (Md) age was 76 for CT and 65 for the RPP. The CT group was predominantly 
male. A significant difference (p=0.037) between the age of males (Md=63) and females  
 
Characteristic 
RPP n=148 CT n=145 
P value 
Md(Min-Max)   Md(Min-Max) 
Age   65 (18-98) 76 (31-97) <0.001 
    
Hemoglobin 13.6 (4.9-19.8) 14.5 (10.2-17.5) 0.001 
Glomerular Filtration Rate 51 (2.1-147) 47 (16.6-115.8) 0.027 
Body Mass Index 26.1 (18.2-46.5) 25.3 (15.1-39.1) 0.149 
Mean Arterial Pressure 93.3 (75-123.3) 93.3 (58.3-120.7) 0.529 
 n (%) n (%) P value 
Gender    
  Male 77 (52.0) 119 (82.1) 
<0.001 
  Female 71 (48) 26 (27.9) 
    
Stage    
   1 and 2 44 (29.7) 18 (12.4) 
<0.001 
   3, 4 and 5 104 (70.3) 127 (87.6) 
Comorbidities   
   Arterial Hypertension 141 (95.3) 133 (91.7) 0.218 
   Diabetes  60 (40.5) 44 (30.3) 0.068 
   Dyslipidemia 92 (62.2) 106 (73.1) 0.045 
RPP: Renal Protection Program. CT: Conventional treatment; Md: Median. Min: minimum value.  
Max: maximum value. 
Table 1. Distribution of demographic and clinical characteristics of predialysis patients with 
chronic renal failure. Medellin, 2007-2008. 
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(Md=68) was found in the RPP group. Clinical parameters such as arterial pressure, serum 
creatinine, and body mass index showed no significant differences between the study 
groups. For the CT group, serum hemoglobin values were significantly higher, and the 
glomerular filtration rate was lower. Most patients in both healthcare providing institutions 
had a history of arterial hypertension (90%) and dyslipidemia (60%). Distribution by stages 
showed that patients joined the Renal Protection Program at early stages of their condition 
(1 and 2=29.7 %), whereas CT patients requested treatment when their disease was at later 
stages (1 and 2=12.4%). See Table 1. 
3.2 Perception of health-related quality of life 
At the start of the study, the perception of HRQOL measured by the SF-36 showed no 
significant differences between the RPP and CT, except for MCS1 and role-emotional. 
However, the effect size (ES) was 0.08 and 0.13 respectively. The only domain exhibiting 
significant differences after one year was change in health, whose values  favored the RPP 
with ES=0.11 (See Table 2). 
As for the changes within each group after one year, the RPP patients showed a significant 
decrease only in physical functioning (p=0.038; ES=0.14), whereas CT patients showed a 
decrease in four domains: physical functioning (p=0.027; ES=0.14), general health (p=0.001; 
ES=0.29), social functioning (p=0.010; ES=0.22), and vitality (p=0.009; ES=0.22) and in MCS1 




Initial 1 year 
RPP CT: t-Student RPP CT: t-Student 
Mean (SD) Mean (SD) P value Mean (SD) Mean (SD) P value 
PCS1: 60.9 (28.4) 58.5 (27.6) 0.470 58.9 (27.6) 54.2 (28.7) 0.160 
Physical Functioning 70.0 (27.4) 68.7 (26.4) 0.662 65.8 (30.6) 64.3 (31.1) 0.684 
Role-Physical 62.0 (41.4) 63.3 (42.9) 0.795 66.4 (42.3) 59.7 (45.5) 0.191 
Bodily Pain 66.7 (28.6) 67.8 (27.4) 0.733 65.0 (28.3) 64.2 (29.1) 0.808 
General Health 58.8 (23.6) 60.4 (22.4) 0.554 57.6 (23.5) 53.1 (26.0) 0.125 
MCS1: 67.1 (33.2) 75.1 (28.1) 0.027 69.4 (27.6) 69.7 (27.4) 0.917 
Mental Health 69.6 (26.8) 73.3 (23.8) 0.219 68.1 (24.5) 69.8 (23.8) 0.539 
Role-Emotional 64.8 (43.1) 76.0 (37.1) 0.017 71.0 (40.9) 70.1 (40.4) 0.858 
Social Functioning 76.3 (29.1) 80.9 (27.0) 0.160 77.3 (26.6) 74.5 (28.5) 0.390 
Vitality 67.4 (27.0) 67.8 (24.6) 0.905 64.9 (24.9) 61.9 (26.3) 0.315 
Changes in Health 66.1 (23.9) 65.9 (21.1) 0.955 68.5 (23.2) 62.6 (22.9) 0.029 
RPP: Renal Protection Program. CT: Conventional treatment; PCS1: Physical health summary score. 
MCS1: Mental health summary score. SD: Standard deviation 
Table 2. Distribution of HRQOL scores in patients with chronic renal failure in predialysis 
before and after an intervention. Medellín, 2007-2008. 
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Initial 1 year 
Female Male t-Student Female Male t-Student 
Mean (SD) Mean (SD) P value Mean (SD) Mean (SD) P value 
RPP        
PCS1: 54.6 (27.7) 66.6 (28.0) 0.010 53.0 (26.4) 64.3 (27.8) 0.013 
Physical Functioning 61.5 (27.4) 77.9 (25.1) <0.001 57.3 (30.8) 73.6 (28.3) 0.001 
Role-Physical 53.2 (41.8) 70.1 (39.5) 0.012 62.0 (44.7) 70.5 (39.9) 0.224 
Bodily Pain 61.3 (28.5) 71.7 (28.0) 0.026 59.4 (27.3) 70.2 (28.3) 0.021 
General Health 52.4 (22.2) 64.7 (23.5) 0.001 53.8 (22.6) 61.1 (23.9) 0.059 
       
MCS1: 59.4 (36.1) 74.3 (28.6) 0.006 64.4 (28.7) 74.0 (25.8) 0.034 
Mental Health 62.5 (29.1) 76.2 (22.7) 0.002 63.5 (23.5) 72.3 (24.9) 0.028 
Role-Emotional 52.0 (45.0) 76.5 (37.9) <0.001 64.5 (43.1) 77.0 (38.0) 0.065 
Social Functioning 74.0 (29.7) 78.5 (28.6) 0.354 73.7 (28.4) 80.7 (24.6) 0.109 
Vitality 59.6 (27.5) 74.6 (24.6) 0.001 56.1 (23.9) 73.0 (23.2) <0.001* 
CHANGES IN 
HEALTH 65.1 (23.6) 67.0 (24.2) 0.622 66.2 (21.0) 70.6 (25.0) 0.245 
              
CT:       
PCS1: 51.3 (27.8) 60.1 (27.4) 0.142 47.6 (28.5) 55.7 (28.7) 0.198 
Physical Functioning 61.5 (28.8) 70.2 (25.7) 0.130 55.6 (30.6) 66.3 (31.0) 0.112 
Role-Physical 48.1 (43.0) 66.6 (42.3) 0.046 47.1 (44.9) 62.4 (45.3) 0.121 
Bodily Pain 57.1 (29.0) 70.1 (26.6) 0.027 49.9 (25.7) 67.3 (29.0) 0.005+ 
General Health 61.9 (21.9) 60.0 (22.6) 0.700 59.6 (24.7) 51.7 (26.2) 0.162 
       
MCS1: 65.9 (28.9) 77.1 (27.6) 0.065 61.4 (27.5) 71.5 (27.1) 0.086 
Mental Health 61.5 (24.0) 75.8 (23.1) 0.005 64.5 (17.7) 70.9 (24.8) 0.213 
Role-Emotional 66.6 (43.2) 78.0 (35.4) 0.216 52.5 (42.1) 74.0 (39.2) 0.013 
Social Functioning 74.4 (30.2) 82.4 (26.2) 0.176 67.8 (21.5) 76.0 (29.7) 0.180 
Vitality 58.5 (23.4) 69.8 (24.5) 0.033 56.9 (20.0) 62.9 (27.5) 0.292 
CHANGES IN 
HEALTH 60.8 (21.5) 67.1 (20.9) 0.169 71.5 (18.9) 60.7 (23.3) 0.028 
RPP: Renal Protection Program. CT: Conventional treatment PCS1: Physical health summary score. 
MCS1: Mental health summary score. SD: Standard deviation     
*: Effect size =0.69     +: Effect size =0.61 
Table 3. Distribution of  HRQOL scores, by gender, in patients with chronic kidney disease 
in predialysis before and after an intervention. Medellín, 2007-2008. 
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3.3 Perception of health-related quality of life in terms of gender 
In both groups HRQOL was lower for women both in the initial measurement and in the 
final measurement after one year. At the start of the study, the female patients of the RPP 
showed significant differences in most domains, and CT female patients showed these only 
in a few domains. One year later, the HRQOL difference between men and women in the 
RPP group remained unchanged for PCS1 (ES=0.40) and MCS1 (ES=0.34), and for the 
following domains: physical functioning (ES=0.53), bodily pain (ES=0.37), mental health 
(ES=0.35) and vitality (ES=0.69). For the CT group, the only significant differences were in 
bodily pain (ES=0.61), role-emotional (ES=0.51) and change in health (ES=0.48). See Table 3. 
After one year, women within each group showed no changes in HRQOL measurements. 
Only the men following CT showed a significant decrease in general health (p=0.001 
ES=0.33), social functioning (p=0.014 ES=0.15), vitality (p=0.007 ES=0.13), and change in 
health (p=0.012 ES=0.09). 
3.4 Perception of health-related quality of life in terms of age 
In both interventions, the physical component of HRQOL was more affected in patients 
older than 65 than in younger individuals. This was constant throughout the study. In the 
RPP group, these differences at the start of the study and one year later were statistically 
significant for PCS1 (p=0.001, ES start=0.08; p<0.001, ES year=0.06), for the physical 
functioning domain (p=0.001, ES start=0.30; p<0.001, ES year=0.03) and for bodily pain 
(p=0.009, ES start=0.02; p=0.025, ES year=0.10). In CT, however, the differences found 
between the age groups at the start were in PCS1 (p=0.025, ES start=0.44), in the physical 
functioning domain (p=0.001, ES start=0.61) and in role-physical (p=0.022, ES start=0.43). 
One year later, differences were found in physical functioning (p=0.022, ES year=0.57) and 
general health (p=0.021, ES year=0.45). See Table 4. 
After analyzing changes within each group and for each age group, it was observed that the 
RPP patients who were 65 and older showed significant changes in physical functioning 
(p=0.006, ES=0.30) after one year. Patients younger than 65 showed no changes after this 
time. In CT, patients younger than 65 showed significant changes in MCS1 (p=0.044, 
ES=0.34) and in the social functioning domain (p=0.003, ES=0.53). Patients who were 65 and 
older showed changes after one year in physical functioning (p=0.050, ES=0.15), general 
health (p=0.001, ES=0.35) and vitality (p=0.044, ES=0.20) See Table 4. 
3.5 Health-related quality of life adjusted for previous measurements, age, and gender 
After adjusting the second measurement's raw HRQOL score (See Table 2) for the initial 
HRQOL score, significant differences were found between the RPP and the CT groups in the 
following domains: general health (a difference of 5.2 points favoring the RPP) and change 
in health (the difference of 5.9 points continues to favor the RPP). After adjusting it for 
gender, differences were found in PCS1 (a difference of 7.7 points favoring the RPP) and 
vitality (a difference of 6.9 points favoring the RPP). When the score was adjusted for age, 
differences were then found in physical functioning (a difference of 7.2 points favoring CT). 
No significant differences were found upon adjusting HRQOL for stage, hypertension, 
diabetes, and dyslipidemia (See Table 5). 
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Mean (SD) Mean (SD) P value Mean (SD) Mean (SD) P value 
RPP        
PCS1: 53.3 (28.0) 68.9 (26.8) 0.001 51.0 (27.1) 67.2 (25.9) <0.001 
Physical Functioning 62.7 (26.1) 77.8 (26.9) 0.001 53.8 (30.7) 78.5 (24.9) <0.001 
Role-Physical 57.9 (42.5) 66.3 (40.1) 0.217 60.2 (43.8) 72.9 (40.0) 0.067 
Bodily Pain 60.7 (29.5) 73.0 (26.4) 0.009 60.0 (30.6) 70.4 (24.7) 0.025 
General Health 56.0 (24.3) 61.7 (22.7) 0.140 56.6 (24.9) 58.6 (22.0) 0.613 
       
MCS1: 70.7 (32.9) 63.4 (33.2) 0.178 68.5 (31.3) 70.2 (23.2) 0.708 
Mental Health 69.5 (29.1) 69.8 (24.3) 0.945 67.5 (28.2) 68.6 (20.2) 0.793 
Role-Emotional 67.0 (42.7) 62.4 (43.7) 0.518 64.6 (43.7) 77.7 (36.7) 0.051 
Social Functioning 76.9 (30.3) 75.7 (27.9) 0.809 73.7 (29.2) 81.2 (23.2) 0.085 
Vitality 66.2 (26.8) 68.7 (27.3) 0.576 61.2 (26.5) 68.7 (22.7) 0.068 
CHANGES IN 
HEALTH 62.4 (23.1) 70.0 (24.2) 0.052 61.3 (24.3) 76.1 (19.5) <0.001 
              
CT:       
PCS1: 55.7 (27.6) 67.9 (25.8) 0.025 51.9 (28.3) 62.2 (29.0) 0.068 
Physical Functioning 65.2 (27.0) 80.5 (20.9) 0.001 60.5 (31.8) 77.4 (24.8) 0.002 
Role-Physical 59.2 (43.8) 77.3 (37.2) 0.022 58.3 (45.2) 64.4 (46.8) 0.498 
Bodily Pain 66.7 (28.1) 71.5 (25.1) 0.377 64.8 (28.5) 62.2 (31.6) 0.648 
General Health 59.2 (22.8) 64.2 (21.2) 0.262 50.4 (25.7) 62.3 (25.3) 0.021 
       
MCS1: 73.8 (28.9) 79.6 (24.8) 0.302 69.9 (27.0) 69.0 (28.9) 0.875 
Mental Health 71.8 (24.5) 78.3 (20.9) 0.167 69.5 (24.3) 70.7 (22.1) 0.811 
Role-Emotional 73.4 (39.1) 84.7 (27.9) 0.068 69.0 (41.4) 74.1 (37.1) 0.520 
Social Functioning 79.1 (28.1) 87.1 (22.0) 0.136 74.8 (29.0) 73.7 (27.0) 0.851 
Vitality 66.0 (24.9) 73.8 (23.0) 0.110 60.7 (26.8) 65.8 (24.6) 0.325 
CHANGES IN 
HEALTH 64.3 (21.0) 71.5 (20.6) 0.084 61.4 (23.2) 66.7 (21.6) 0.249 
RPP: Renal Protection Program. CT: Conventional treatment PCS1: Physical health summary score. 
MCS1: Mental health summary score. SD: Standard deviation 
Table 4. Distribution of HRQOL scores, by age, in patients with chronic renal failure in 
predialysis before and after an intervention. Medellín, 2007-2008. 
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Mean adjusted for 
initial  HRQOL 
Mean adjusted for 
gender 
Mean adjusted for 
age 
RPP CT: RPP CT: RPP CT: 
PCS1: 58.2 54.9 58.7** 51.0** 56.0 57.1 
Physical Functioning 65.3 64.9 65.5 59.8 61.5* 68.7* 
Role-Physical 66.7 59.4 66.2 56.1 64.3 61.7 
Bodily Pain 65.3 64.0 64.8 60.0 63.6 65.6 
General Health 58.0* 52.8* 57.6 52.6 56.6 54.2 
       
MCS1: 70.5 68.6 69.2 66.6 69.2 69.9 
Mental Health 68.7 69.1 67.9 67.2 67.7 70.2 
Role-Emotional 72.5 68.6 70.7 65.1 69.2 71.9 
Social Functioning 78.0 73.8 77.2 72.1 76.3 75.6 
Vitality 65.0 61.8 64.6** 57.7** 63.5 63.3 
CHANGES IN 
HEALTH 68.5* 62.6* 68.5 63.0 67.2 64.0 
RPP: Renal Protection Program. CT: Conventional treatment PCS1: Physical health summary score. 
MCS1: Mental health summary score.  
The underlined values correspond to significant difference by intervention type and by adjustment 
variable.   P value: * p<0.05   **p<0.01.      
Table 5. Distribution of health-related quality of life scores in patients with chronic renal 
failure in predialysis after one year of treatment. Scores are adjusted for initial health-related 
quality of life, gender, and age. Medellín, 2007-2008. 
3.6 Reasons for not participating in the study 
The reasons for the unreachability of the remaining 118 patients during the first 
measurement were: wrong phone number = 43 (40% RPP), occupation = 33 (45% RPP), 
being out of geographical reach = 17 (35% RPP), and exclusion criteria = 14 (57% RPP). Only 
11 patients (36% RPP) were excluded due to concomitant disease or death, which is 
associated with a decrease in HRQOL. One year later, of the missing RPP patients: 6 refused 
to participate (2 due to disease), 6 couldn't be contacted, and 3 had died. In CT: 5 refused to 
participate (1 due to disease), 4 couldn't be contacted, and 6 had died. 
4. Discussion 
This is the first report in Colombia to provide an account of the factors affecting HRQOL in 
patients with mild to moderate renal impairment. It is also the first to point out the 
advantages that a renal protection program may have over conventional treatment 
regarding its impact on patient HRQOL. This study's results are presented to comply with 
the demands that appear in international literature regarding the need to determine the 
impact on HRQOL in early stages of renal impairment (Chandban et al., 2003; Perlman et al., 
2005) and to insist that current interventions must emphasize the preservation of renal 
functioning in order to decrease the negative impact of kidney failure on HRQOL 
(Chandban et al., 2003; Fukuhara et al., 2007; Valdebarrano et al., 2001).  
www.intechopen.com
 Chronic Kidney Disease 
 
440 
The study's data were collected from 293 patients in the early stages of CRF. Patients followed 
two kinds of medical treatment during one year. The groups showed no differences for the 
main comorbidities, but it was evident that the RPP collected more patients in earlier stages of 
CRF due to its active search. The higher proportion of male patients in CT could be due to the 
faster progression of CRF in males (Silbiger & Neugarten, 1995). This could explain the gender 
and age disparities found between the groups at the start of the study.  
One year later, the RPP group’s scores for the different HRQOL domains were slightly 
lower, but these differences were not significant. Conversely, the CT group showed a 
significant decrease in four of the eight domains after the same time. This accounts for the 
effect of the RPP even in a short follow-up period. It is worth noting that general health was 
the most affected domain in both groups. After one year, the initial value for the RPP 
remained unchanged, but decreased drastically for CT.  
The results obtained from data collected from predialysis patients confirm that HRQOL is 
affected from the early stages of CRF and continues to decrease as the condition evolves. 
Even after only one year, the scores for most domains decreased. This conclusion is shared 
by other studies whose patients lacked RRT. The population assessed in such studies was 
Japanese (Fukuhara et al., 2007), African-American (African American Study of Kidney 
Disease and Hypertension Trial Group [AASK], 2002), Australian (Chandban et al., 2005), 
Korean (Chin et al., 2008), and Dutch (Korevaar et al., 2000). 
In this study, the physical health of predialysis patients was found to be more affected than 
their mental health. This was true for both study groups. These findings are in accordance 
with the conclusions reached in other publications on the same topic (Chandban et al., 2005; 
Fukuhara et al., 2007; AASK, 2002; Korevaar et al., 2000; Hopman et al., 2000). Regarding 
mental health, CT patients initially showed significantly superior values compared to the 
RPP patients. This result is consistent with the ideas exposed in other studies, which suggest 
that older patients —or those with an older diagnosis— have better mental health. This 
proves that mental health is worse in young or recently diagnosed individuals (Hopman et 
al., 2000). Nevertheless, one year later, the scores for the mental component of HRQOL 
increased within the RPP group, whereas CT scores decreased, and the initial differences 
between the RPP and CT disappeared.   
Gender was a key factor for the SF-36 scores since its first application. It was observed that 
the scores for women were lower and had significant differences regardless of the group. 
However, these differences disappeared within the RPP group one year later. In CT, 
however, the differences remained and values in men decreased statistically. Other 
researchers also recognized this affectedness of HRQOL by gender. They also proposed that 
women may be particularly more vulnerable (Yepes et al., 2008). This was also done in the 
AASK study (AASK, 2002), which focused on the need for exploring the mechanisms 
allowing HRQOL in female CRF patients to decrease quickly. In studying the HRQOL of the 
Australian population suffering from kidney failure Chandban (Chandban et al., 2005) 
described similar worsening patterns for both genders.  
After one year, women's HRQOL in most domains continued to be worse than that of men. 
However it is worth noting that differences between the values obtained at the start of the 
study and after one year could be indirectly considered as clinically important in the vitality 
values for the RPP (ES=0.69) and the bodily pain values for CT (ES=0.61).  
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Regarding age, patients older than 65 had a lower HRQOL. Physical functioning was the most 
affected domain for the two groups both at the start of the study and one year later. This could 
be explained by the strong negative association between the state of physical health and old 
age. Such association was reported in literature by studies on this and other chronic diseases 
(Chandban et al., 2005; Hopman et al., 2000; Yepes et al., 2008). The RPP patients younger than 
65 showed an increase in four of the domains one year after the start of the study. The rest of 
the domains also decreased, but not significantly, except for the role-physical domain. For the 
CT group, all the domains values decreased in the second measurement, and four of them did 
so significantly. The difference found in physical functioning between the age groups in CT 
according to the effect size (> 0.60) can be considered to be clinically important. This must be 
corroborated for each case with the medical staff. 
It is imperative to adjust the differences found in the final HRQOL scores for the variables that 
can influence such results. As for general health and change in health, upon adjusting for the 
respective value of the initial score, an increase of more than five points of HRQOL was 
generated in the difference that favors the RPP over CT in both domains. In the PCS1 and 
vitality domains, adjusting scores for gender yielded an important increase of the difference in 
favor of the RPP in both cases (Yepes et al., 2008). In physical functioning, adjusting scores for 
age increased the difference in HRQOL scores, favoring CT (Yepes et al., 2008).   
In short, exposure to a RPP has a positive impact on the HRQOL of CRF patients from the 
early stages of their condition. The initial HRQOL score, gender, and age are fundamental 
characteristics to take into account for measuring the HRQOL of patients upon exposure to 
an intervention. It seems that early detection of CRF patients and interdisciplinary control of 
risk factors have a significant influence in the outcome of both physical and mental HRQOL 
measurements.   
HRQOL values have been proposed as an important outcome in patients with high death, 
hospitalization, and depression risks. Measuring the HRQOL with validated instruments 
such as the SF-36 allows it to become a strong indicator of the health-related quality of life in 
ambulatory patients. In fact, it is considered a mortality and morbidity predictor in elderly 
and CRF patients (DeOreo, 1997; Han et al., 2009; Kalantar-Zadeh, 2005; Mapes et al., 2003). 
Assessing the well-being of CRF patients periodically with the SF-36 is important for 
measuring response to treatment and for improving healthcare. In fact, improving the 
HRQOL of CRF patients is a key objective in the U.S (Kalantar-Zadeh, 2005).  
This study's main limitation is its short follow-up period, which could not provide an 
appropriate account of the characteristics of a slow, progressive disease while explaining 
that many changes are not significant enough. Another limitation is that demographic 
variables like marital status, socioeconomic level, occupation, educational level, income, etc., 
were disregarded. Some studies state that both PCS1 and MCS1 are closely associated with 
demographic characteristics that are likely to have a deeper impact than clinical 
characteristics themselves (AASK, 2002; Fukuhara et al., 2007).  
Data loss due to patient death and other causes was expected for the second application of the 
SF-36 one year later. Like many other health scales, the SF-36 has no clear directions regarding 
how deaths within a studied population should be analyzed. This has limited the analysis in 
research. This issue is most frequently addressed by excluding these cases from the study or 
by analyzing these data separately. Paradoxically, if two study groups are compared, the 
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group with more diseased individuals seems to obtain better results. This is because most 
individuals have died and have been thus excluded from the results and from the analysis.  
Due to the negative impact of CRF on HRQOL, it is necessary to determine potential areas 
for research and clinical intervention. Such areas include: psychological support for the most 
vulnerable population (women, young people, recently diagnosed patients, patients in early 
stages of the condition), early prescription of nephroprotectors, and complete physical 
therapy programs focusing on older patients and on those with high deterioration rates. 
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